The Pharmacy Times® Mental Health resource center provides a home where mental health experts and pharmacists can meet to learn about the latest clinical news from the field. With articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content, this is a one-stop shop for folks in both professions.
Caplyta is an atypical antipsychotic and is thought to exert its effect through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.
Kimberly Erlich, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project and Consulting Associate Faculty, Duke University School of Nursing, discusses considerations for pharmacogenomic testing in the pediatric population for behavioral health treatment.
Pharmacy Times®interviewedSusan Van Cleve, Clinical Professor and Primary Care Pediatric Nurse Practitioner program director, University of Iowa College of Nursing, on identifying and treating anxiety in children and teens who present comorbidities.
Kimberly Erlich, MSN, RN, MPH, CPNP, PMHS, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project, discusses pharmacogenomics and behavioral health in treatment of children and teens.
A new study conducted by researchers at Bar-Ilan University and the University of Haifa has linked coronavirus disease 2019 (COVID-19)-based loneliness in older adults with elevated psychiatric symptoms of anxiety, depression, and trauma symptoms that immediately follow exposure to trauma.
Dawn Lee Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, FAAN, the Immediate Past President of NAPNAP and the Associate Professor at the University of Portland in the School of Nursing, discusses caring and prescribing for children with ADHD who have other comorbidities.
The Pharmacy Times® Mental Health specialty page serves as a hub for all clinical news and articles related to mental health conditions, including: anxiety, eating disorders, and, depression. The coverage includes breaking news coverage of therapies recently approved by the US Food and Drug Administration, key takeaways from the latest clinical trials, and notifications of updates to clinical guidelines for countless conditions.